Name: IPO Lysogène
Uploaded: 2017-02-08T10:33:01+0100
Description: Listing of Lysogène on Euronext Karen Aiach, Founder and Managing Director, Lysogène, opens the trading day in Paris. Lysogene is a biotechnology company specializing in the research and development of gene therapies for the treatment of rare neurodegenerative diseases. The company now has 2 products in development phase for the treatment of Sanfilippo syndrom and gangliosidosis.

搜索联络表

This page is available in multiple languages

Select Language

Back

08/02/2017

Listing of Lysogène on Euronext

Karen Aiach, Founder and Managing Director, Lysogène, opens the trading day in Paris.

Lysogene is a biotechnology company specializing in the research and development of gene therapies for the treatment of rare neurodegenerative diseases.
The company now has 2 products in development phase for the treatment of Sanfilippo syndrom and gangliosidosis.